← All organizations

Shanghai Yunying Medical Technology

For profit

Also known as: Shanghai Yunying Medical Technology

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Jul 12, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 8 trials)

Phase 1 (1 own, 0 via acquisition)

recombinant oncolytic herpes simplex virus type 1 (r130)

Recent trials (8)

NCT06171282Lead sponsorEarly Phase 1Jul 12, 2023
NCT05961111Lead sponsorEarly Phase 1Jun 24, 2023
NCT05851456Lead sponsorEarly Phase 1Apr 10, 2023
NCT05886075Lead sponsorEarly Phase 1Mar 30, 2023
NCT05830240Lead sponsorEarly Phase 1Mar 27, 2023
NCT05860374Lead sponsorEarly Phase 1Mar 2, 2023
NCT05812677Lead sponsorEarly Phase 1Feb 6, 2023
NCT05801783Lead sponsorEarly Phase 1Dec 2, 2022

Details

Last known activity: Jul 12, 2023